Anuncio
Anuncio

CMMB

CMMB logo

Chemomab Therapeutics Ltd. - ADR

1.77
USD
Patrocinado
-0.03
-1.39%
09 ene, 15:57 UTC -5
Cerrado
exchange

Post-mercado

1.86

+0.09
+4.79%

Informes de beneficios de CMMB

Ratio de Sorpresa Positivo

CMMB superó 3 de las últimas 20 estimaciones.

15%

Próximo informe

Fecha del próximo informe
02 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.01
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/
--
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/
-98.44%

Chemomab Therapeutics Ltd. - ADR earnings per share and revenue

On 17 nov 2025, CMMB reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.01 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Preguntas frecuentes
For Q3 2025, Chemomab Therapeutics Ltd. - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 02 mar 2026.
Based on 3 analistas, Chemomab Therapeutics Ltd. - ADR is expected to report EPS of -$0.01 and revenue of -- for Q4 2025.
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio